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Abstract
Background: Bacteria can be selectively imaged in experimentally-infected animals using exogenously administered 1-
(29deoxy-29-fluoro-b-D-arabinofuranosyl)-5-[
125I]-iodouracil ([
125I]-FIAU), a nucleoside analog substrate for bacterial
thymidine kinase (TK). Our goal was to use this reporter and develop non-invasive methods to detect and localize
Mycobacterium tuberculosis.
Methodology/Principal Findings: We engineered a M. tuberculosis strain with chromosomally integrated bacterial TK under
the control of hsp60 - a strong constitutive mycobacterial promoter. [
125I]FIAU uptake, antimicrobial susceptibilities and in
vivo growth characteristics were evaluated for this strain. Using single photon emission computed tomography (SPECT), M.
tuberculosis Phsp60 TK strain was evaluated in experimentally-infected BALB/c and C3HeB/FeJ mice using the thigh
inoculation or low-dose aerosol infection models. M. tuberculosis Phsp60 TK strain actively accumulated [
125I]FIAU in vitro.
Growth characteristics of the TK strain and susceptibility to common anti-tuberculous drugs were similar to the wild-type
parent strain. M. tuberculosis Phsp60 TK strain was stable in vivo and SPECT imaging could detect and localize this strain in
both animal models tested.
Conclusion: We have developed a novel tool for non-invasive assessment of M. tuberculosis in live experimentally-infected
animals. This tool will allow real-time pathogenesis studies in animal models of TB and has the potential to simplify
preclinical studies and accelerate TB research.
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Introduction
Current tools for monitoring tuberculosis (TB) in preclinical
animal studies are costly and time consuming. Significant
resources are required for processing (animal sacrifice, organ
harvesting) hundreds of animals per study. Since Mycobacterium
tuberculosis grows slowly, colony forming unit (CFU) counts and
subsequent results are not available for at least 4-weeks after the
completion of the study. Moreover, since the entire organ is
generally homogenized and different animals are sacrificed at each
time-point; lesion-specific responses in the same animal can also
never be assessed.
While mouse chemotherapy is generally concordant with
human studies, and animal-to-animal variability is low owing to
the availability of inbred strains, a significant drawback of the
standard mouse model is the lack of caseation – the hallmark of
human disease. As new drugs and vaccines are developed which
target persistence, characterization of alternative models that
develop microenvironments which are absent in mouse lungs, but
which may be relevant to human TB lesions, is fundamental to
preclinical assessment. Therefore, it may be essential to perform
cross-species studies in larger animal models such as guinea pigs,
rabbits, non-human primates (NHP) which develop microenviron-
ments relevant to human TB [1]. Animal-to-animal variability is a
more serious concern with these larger, more expensive species,
which are generally not available as inbred strains. The need for
non-invasive biomarkers that can monitor response in the same
group of animals and therefore significantly reduce the numbers of
animals required per study will be essential to cost-effectively
conduct these studies in the larger and more expensive animals.
Bacteria can be selectively imaged in experimentally-infected
mice using exogenously administered 1-(29deoxy-29-fluoro-b-D-
arabinofuranosyl)-5-[
125I]-iodouracil ([
125I]FIAU), a nucleoside
analog substrate for bacterial TK [2]. TK phosphorylates FIAU,
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is a poor substrate for mammalian TK, the radiotracer selectively
labels bacteria. These bacteria can therefore be imaged in situ after
an intravenous administration of [
125I]FIAU using single photon
emission computed tomography (SPECT) in conjunction with
computed tomography (CT). Since radio-pharmaceutical based
imaging provides a comprehensive 3-dimensional (3-D) assessment
of the whole organ, it also generally correlates closely with the
overall disease. In this study, we adapted the thymidine kinase
reporter system for M. tuberculosis. Since mycobacteria lack TK, we
engineered and characterized a M. tuberculosis strain expressing TK
and used it to detect and localize M. tuberculosis in live animals in situ.
Methods
M. tuberculosis Phsp60 TK strain
Using the Invitrogen Gateway Cloning system we constructed a
vector, pGS400H, for efficient delivery of a single copy of DNA to
the attB site in the mycobacterial genome. Bacterial TK from
Escherichia coli (Kind gift of Kwang Sik Kim, Johns Hopkins
University) was PCR amplified and cloned into pGS400H
downstream of Phsp60 - a highly active constitutive mycobacterial
promoter [3]. M. tuberculosis H37Rv strain was transformed with
this vector and colonies selected on hygromycin plates using
standard methods. Cloning was confirmed using PCR and
Southern blotting.
M. tuberculosis strains and media
M. tuberculosis H37Rv and M. tuberculosis Phsp60 TK strains were
grown to mid-log phase in plastic roller bottles or as shaken
cultures in plastic tubes at 37uC in Middlebrook 7H9 liquid broth
(Difco Laboratories) supplemented with oleic acid albumin
dextrose catalase (OADC) (Becton Dickinson), 0.5% glycerol,
and 0.05% Tween 80. Hygromycin (50 mg/ml) was used for all M.
tuberculosis Phsp60 TK broth cultures. Before thigh injections,
mycobacteria were washed and resuspended in phosphate
buffered saline (PBS), and their optical densities at 600 nm
(OD600) were adjusted to achieve the required bacterial density. In
addition, 100 mL from each inocula were plated to determine the
colony forming units (CFU) counts. M. tuberculosis were plated onto
Middlebrook 7H11 selective plates (Becton Dickinson).
In vitro [
125I]FIAU uptake
Equal numbers of M. tuberculosis H37Rv (wild-type) or M.
tuberculosis Phsp60 TK strains were incubated with 1 mCi/ml of
[
125I]FIAU at 37uC in Middlebrook 7H9 liquid broth for 6 and
24 hours. At each specified time-point equal aliquots were
withdrawn from the cultures and washed 3 times to remove free
[
125I]FIAU in the media. Each pellet was resuspended in PBS in
1.5 ml Eppendorf tubes and disinfected with Lysol overnight. The
activity for each Eppendorf was measured using an automated
gamma counter (1282 Compugamma CS Universal gamma
counter, LKB Wallac). Each assay was performed in triplicate.
Antimicrobial susceptibilities
M. tuberculosis H37Rv and M. tuberculosis Phsp60 TK strains were
tested against common anti-TB drugs (streptomycin, ethambutol,
INH, rifampin and moxifloxacin) and FIAU (non-radioactive)
using the standard broth dilution method. Briefly, mid-log phase
bacteria were diluted to a concentration of 100,000 organisms/ml
and grown at 37uC in Middlebrook 7H9 liquid broth (without
Tween 80) containing different concentrations of antibiotics. Mean
inhibitory concentrations (MIC) were determined 10–14 days
later. Each assay was performed in triplicate.
Animal infection
5–6 week old female BALB/c (Charles River) or C3HeB/FeJ
(Jackson Laboratory) mice were used. Equal numbers of M.
tuberculosis H37Rv or M. tuberculosis Phsp60 TK strains in 50–100 ml
of PBS were inoculated into either thigh of BALB/c mice.
C3HeB/FeJ mice were low-dose aerosol infected with equal
numbers of either M. tuberculosis H37Rv or M. tuberculosis Phsp60 TK
strains using the Inhalation Exposure System (Glas-Col). Three
mice were sacrificed at 1-day and 2-weekly intervals thereafter,
and the lungs homogenized and plated for CFU to determine the
number of bacilli implanted and bacterial growth respectively.
Using TK specific primers and colony PCR, the TK gene was
amplified from randomly picked M. tuberculosis Phsp60 TK colonies.
Colonies obtained from M. tuberculosis wild-type infected mice and
pGS400H vector were used as negative and positive controls
respectively.
Bio-containment and anesthesia
All live M. tuberculosis infected animals were imaged within a
sealed bio-containment device developed by our laboratory. An
unbreakable and transparent centrifuge bottle with a gasket screw
cap (Nalgene) and holes for passage of gases was used for this
purpose. Two 0.22 mm filters were used both at the inlet and the
outlet to contain the bacteria within the device. A standard small
animal anesthesia machine was used to deliver an Isoflurane
(Henry Schein) oxygen mixture during transport and imaging.
Animals were anesthetized and sealed inside the bio-containment
device in the BSL-3 facility. The external surface of the bio-
containment device was decontaminated and transported to the
imaging suite. During prolonged anesthesia (.20 min), an
infrared thermometer and a heat-lamp were used to measure
and maintain ambient air temperature inside the bio-containment
device.
Imaging
BALB/c mice were imaged 3 and 12 hours after the thigh
inoculation while C3HeB/FeJ mice were imaged at 6 or 8 weeks
after the low-dose aerosol infection. Before imaging, each mouse
was weighed, injected with 1 mCi of [
125I]FIAU via the tail-vein
and enclosed in the bio-containment device. Mice were imaged 3–
24 hours post-injection using the X-SPECT (Gamma Medica) or
NanoSPECT/CT (BIOSCAN) Small Animal SPECT/CT imag-
ers with 45 minutes static acquisitions with 128 projections, or
60 minutes with 48 projections respectively. A CT scan was also
performed at the same time. All images were scaled to the same
level for comparison. SPECT images were reconstructed and co-
registered with CT images using Amira (Visage Imaging). After
imaging, lung tissues from M. tuberculosis H37Rv (wild-type) or M.
tuberculosis Phsp60 TK infected animals were also disinfected and
analyzed using the automated gamma counter.
All protocols were approved by the Animal Care and Use
Committee, Bio-safety and Radiation-safety offices at Johns
Hopkins University.
Statistical analysis. Statistical comparison between groups
were performed using one tail distribution, two sample, unequal
variance t-test in Excel 2007 (Microsoft). Data are presented as
mean6standard deviation throughout the study.
Results
M. tuberculosis Phsp60 TK strain actively accumulates
[
125I]FIAU
We were successful in engineering a strain of M. tuberculosis
H37Rv expressing TK under the control of Phsp60 - a highly active
In Situ TB Imaging
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tuberculosis Phsp60 TK strain actively accumulated [
125I]FIAU in
vitro. Mean uptake activity was 60866536 and 801163233 counts
per minute (cpm) at 6 and 24 hours for the M. tuberculosis Phsp60
TK strain which were significantly more than 549650 and
6156260 cpm for the M. tuberculosis wild-type parent strain
(p,0.03).
Antimicrobial susceptibilities for M. tuberculosis Phsp60 TK
strain are similar to the wild-type strain
Since we plan to develop the M. tuberculosis Phsp60 TK strain as a
reporter for bacterial burden in situ including TB drug develop-
ment, we wanted to evaluate whether this strain has any alteration
in antimicrobial susceptibility to common anti-TB drugs. Table 1
shows the MICs for 5 common anti-TB drugs for M. tuberculosis
Phsp60 TK strain and the M. tuberculosis wild-type strain. As shown,
there is no significant difference between the susceptibility patterns
for either strain. Since FIAU may inhibit bacterial growth of
strains expressing TK [2], we also wanted to evaluate whether M.
tuberculosis Phsp60 TK strain would be inhibited by non-radioactive
FIAU at concentrations achieved in vivo. However, FIAU at up to
8 mg/ml (hundreds of fold higher than achieved in vivo after a
standard animal dose), did not inhibit the growth of M. tuberculosis
Phsp60 TK strain.
M. tuberculosis Phsp60 TK strain is stable in vivo and its
growth characteristics are similar to the wild-type strain
In vitro growth of the M. tuberculosis Phsp60 TK strain was similar
to the wild-type parent strain. Next we evaluated whether the in
vivo growth characteristics of M. tuberculosis Phsp60 TK strain were
also similar to the wild-type parent strain. Figure 1B shows that
both strains grow similarly in the lungs of C3HeB/FeJ mice after a
low-dose aerosol infection. Using TK specific primers and colony
PCR, the TK gene was reliably amplified from all the randomly
picked M. tuberculosis Phsp60 TK colonies (n=13) obtained from
lung homogenates 8-weeks after aerosol infection (Figure 1C) but
not from the negative control.
Figure 1. Characteristics of the Mycobacterium tuberculosis Phsp60 TK strain. A. Equal numbers of M. tuberculosis H37Rv (wild-type) or M.
tuberculosis Phsp60 TK strains were incubated with 1 mCi/ml of [
125I]FIAU at 37uC in Middlebrook 7H9 liquid broth for 6 and 24 hours. At each specified
time-point equal aliquots were withdrawn from the cultures and washed 3 times to remove the media. Each pellet was resuspended in PBS in 1.5 ml
Eppendorf tubes and disinfected with Lysol overnight. The activity for each Eppendorf was measured using a gamma counter. M. tuberculosis Phsp60
TK strain actively accumulates [
125I]FIAU in vitro. Mean uptake activity is 6086 (6536) and 8011 (63233) counts per minute (cpm) at 6 and 24 hours
for the M. tuberculosis Phsp60 TK strain which is significantly more than 549 (650) and 615 (6260) cpm for the wild-type parent strain (p,0.03). B. We
evaluated the in vivo growth characteristics of M. tuberculosis Phsp60 TK strain and compared it to the wild-type parent strain. Both strains grow
similarly in the lungs of C3HeB/FeJ mice after a low-dose aerosol infection. C. Using TK specific primers and colony PCR, the TK gene is reliably
amplified from all the randomly picked M. tuberculosis Phsp60 TK colonies (n=13) obtained from lung homogenates 8-weeks after an aerosol infection
(panel B). +ve and –ve refer to the positive (pGS400H) and negative (M. tuberculosis wild-type) controls respectively.
doi:10.1371/journal.pone.0006297.g001
Table 1. Antimicrobial susceptibilities for Mycobacterium
tuberculosis Phsp60 TK strain are similar to the wild-type parent
strain.
Antibiotic
M. tuberculosis Phsp60
TK strain
M. tuberculosis
wild-type strain
Streptomycin 1 1
Ethambutol 1 2
INH 0.06 0.06
Rifampin 0.25 0.5
Moxifloxacin 0.5 0.5
M. tuberculosis H37Rv and M. tuberculosis Phsp60 TK strains were tested against
common anti-TB drugs (streptomycin, ethambutol, INH, rifampin and
moxifloxacin) using the standard broth dilution method. Mid-log phase bacteria
were diluted to a concentration of 100,000 organisms/ml and grown at 37uCi n
Middlebrook 7H9 liquid broth (without Tween 80) containing different
concentrations of antibiotics. Mean inhibitory concentrations (MIC) were
determined 10–14 days later. As shown, there is no significant difference
between MICs for 5 common anti-TB drugs for either strain.
doi:10.1371/journal.pone.0006297.t001
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125I]FIAU-SPECT can detect and localize M. tuberculosis
Phsp60 TK strain in situ
M. tuberculosis wild-type or M. tuberculosis Phsp60TK strain (,10
8
CFU) were inoculated into either thigh of a BALB/c mouse.
Before imaging, 1 mCi of [
125I]FIAU was injected into each
mouse via a tail vein injection. As shown in Figure 2, SPECT
signal was detected as early as 3 hours from the thigh inoculated
with M. tuberculosis Phsp60TK strain but not from the thigh with the
wild-type strain. As expected, SPECT signal was detected in
several tissues (liver, gall bladder, stomach, gastrointestinal tract,
urinary bladder) that either metabolize or excrete FIAU or its
iodinated derivatives [2,4].
Next we evaluated whether the M. tuberculosis Phsp60 TK strain
could be visualized in lungs of mice that develop caseating lesions.
Day 1 lung implantations after a low-dose aerosol infection were
1.3660.17 and 1.9560.07 log10 CFU for mice infected with the
M. tuberculosis Phsp60TK and M. tuberculosis wild-type strains
respectively. Before imaging, 1 mCi of [
125I]FIAU was injected
into each mouse via a tail vein injection. Figure 3 shows
[
125I]FIAU-SPECT/CT images from the lungs of C3Heb/FeJ
mice infected with either M. tuberculosis Phsp60TK or wild-type
strains 6 or 8-weeks after a low-dose aerosol infection. SPECT
activity was visualized in the lungs of mice infected with the M.
tuberculosis Phsp60TK strain at both time-points (panels A, C).
Though extensive lung disease was present, no SPECT activity
was detected in the lungs of mice infected with the M. tuberculosis
wild-type strain (panel B). As shown in panels C and D, the
SPECT signal from the mouse infected with the M. tuberculosis
Phsp60TK strain localized to the TB granuloma. Ex-vivo radioac-
tivity in the selected granuloma was 5318 cpm per milligram of
tissue compared with 2364 in lung tissue outside of the granuloma
and 856 in lung tissue from the animal infected with M. tuberculosis
wild-type strain.
Discussion
Our overall goal was to develop a method to non-invasively
detect and localize M. tuberculosis in experimentally-infected
animals. We focused on using radiopharmaceutical-based imaging
(CT, PET and SPECT) since it is already extensively used in
humans. Moreover, unlike bioluminescence imaging (BLI),
detection by radiopharmaceutical-based imaging is not limited
by the location or depth of the signal. This means that bacteria or
tissue deep inside the body or near the surface will be visualized
equally well. Further, unlike some forms of BLI which require
genetically modified mouse strains, radiopharmaceutical-based
imaging techniques do not have such limitations, permitting their
use in animal models with maximal relevance to human
physiology. We have also recently shown that BLI is fraught with
another significant problem, namely, that D-luciferin, the
substrate used for imaging with firefly luciferase, is also a substrate
for a multidrug (MDR) resistance pump in host-cells. Accordingly,
differential expression of this MDR pump in the host-tissues
substantially influences D-luciferin dependent bioluminescence in
vivo, confounding the BLI readout [5]. It should however be noted
that BLI imaging is likely to be more sensitive in detecting small
numbers of bacteria than radiopharmaceutical-based imaging.
Though other investigators have used viral tk expression systems
for FIAU imaging, we utilized a bacterial tk gene to ensure the
likelihood of efficient translation and activity in M. tuberculosis.
Moreover, we engineered the M. tuberculosis TK reporter strain
utilizing a plasmid that integrates chromosomally and delivers only
a single copy of the gene allowing more consistent expression. This
method would also theoretically produce a more stable strain, and
in this study, the M. tuberculosis Phsp60TK strain was stable even
after several weeks of in vivo growth without antibiotic selection
pressure. Moreover, these in vivo passaged strains maintained their
[
125I]FIAU uptake phenotype (data not shown). High levels of tk
expression by the Phsp60 could possibly be toxic to the
mycobacteria, though this was not observed in this study. M.
tuberculosis Phsp60TK growth characteristics and antimicrobial
susceptibilities were similar to the wild-type parent strain. Finally,
FIAU at high concentrations (.32 mg/ml) is known to inhibit
growth of bacteria that have endogenous TK [2]. Standard dose of
[
125I]FIAU per animal of 2–5 mCi is equivalent to 0.34–0.85 mgo f
FIAU per animal. Since we have shown that FIAU concentration
of up to 8 mg/ml have no significant affect on the in vitro growth of
M. tuberculosis Phsp60TK strain, we did not anticipate any significant
effect of FIAU on the TK strain in vivo. In fact, bacterial CFUs
recovered from the lungs of mice infected with M. tuberculosis
Figure 2. [
125I]FIAU-SPECT can detect and localize Mycobacterium tuberculosis Phsp60 TK strain in situ. M. tuberculosis H37Rv wild-type or
Phsp60TK strain (,10
8 CFU) were inoculated into either thighs of a BALB/c mouse. 1 mCi of [
125I]FIAU was injected via a tail vein injection. Panels A
and B show the fused SPECT and CT images 3 and 12 hours after the [
125I]FIAU injection. Signal is detected at both time-points in the thigh
inoculated with M. tuberculosis Phsp60TK strain but not in the thigh inoculated with the wild-type strain. As expected, SPECT signal is detected in
several tissues [liver/gall bladder (L), stomach (St), gastrointestinal tract (GI), urinary bladder (UB)] that either metabolize or excrete FIAU or its
iodinated derivatives.
doi:10.1371/journal.pone.0006297.g002
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125I]FIAU injection and SPECT imaging
were not significantly different from those that were not
administered [
125I]FIAU (data not shown).
It has been previously reported that [
125I]FIAU-SPECT can
detect as few as 2 million Staphylococcus aureus per gram of tissue [2].
Our data from both the thigh and aerosol models suggests that
[
125I]FIAU-SPECT can detect as few as 5–10 million M.
tuberculosis Phsp60TK inside a TB granuloma. This is significantly
lower than the bacillary burden (10
7–10
9) observed in a cavitary
TB granuloma during active TB in humans [6]. Therefore, this
method would be useful in monitoring similar TB lesions in other
animal models of TB such as guinea pigs, rabbits and NHP.
However, by utilizing other radio-iodine isotopes (I-123, I-124), we
can expect far greater (5–50 fold) sensitivity. Unfortunately, these
isotopes are significantly more expensive. Use of more active
mycobacterial promoters such as PA37 and PblaF* [7,8] driving TK
expression or TK substrates more specific for bacterial TK, may
also increase sensitivity. Due to limited blood supply at the center
of granulomas, it is possible that this site may be inaccessible to
imaging substrates. However, our data suggests that FIAU was
able to diffuse well into the necrotic granulomas. Finally, it should
be noted that TK activity requires ATP. Quiescent bacteria may
not trap significant amounts of FIAU and therefore may not be
visualized well.
Non-invasive imaging technologies can be used for serial
monitoring of TB disease in real-time in live animals. Since the
same animals would be assessed at the different time-points,
imaging would utilize significantly fewer animals. In other studies,
Figure 3. Mycobacterium tuberculosis Phsp60 TK signal localizes to caseating granulomas in lungs of C3HeB/FeJ mice. A. [
125I]FIAU-
SPECT/CT images from M. tuberculosis Phsp60TK infected C3Heb/FeJ mice 6-weeks after a low-dose aerosol infection. 3-D co-registered SPECT (blue/
red) and CT (yellow) images are also shown. SPECT signal co-localizes to TB granulomas in the lungs of M. tuberculosis Phsp60TK infected mouse
(arrows). B. Though extensive lung disease is present, images from M. tuberculosis wild-type infected mouse show no SPECT activity in the lungs. C.
M. tuberculosis Phsp60TK SPECT signal localizes to a TB granuloma (arrows) in C3Heb/FeJ mice imaged 8-weeks after infection. D. The same lung and
TB granuloma (arrow) is shown post-mortem. Ex-vivo radioactivity in the selected granuloma was 5318 counts per minute per milligram of tissue
compared with 2364 in lung tissue outside of the granuloma and 856 in lung tissue from the animal infected with M. tuberculosis wild-type strain
(St=Stomach).
doi:10.1371/journal.pone.0006297.g003
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18F]FDG-PET activity correlates with
bactericidal activity of anti-TB regimens. Since [
18F]FDG is
marker of metabolic activity and inflammation, changes in
[
18F]FDG-PET activity temporally lagged the changes in bacterial
burden [9]. Moreover, since inflammation generally lags bacterial
burden during TB treatment [10], novel imaging biomarkers that
directly label bacteria (FIAU) are anticipated to provide better
real-time information. Non-invasive assessment would also be very
useful for relapse studies where the time-interval between
development of relapse and cessation of TB treatment is often
unknown and large numbers of mice must be sacrificed at multiple
time-points in order to have enough statistical power to detect
differences in this binary endpoint.
Since the BALB/c mouse model lack well-defined granulomas
that characterize human disease, we wanted to study [
125I]FIAU-
SPECT imaging in a model that develops caseous TB granulomas.
To simulate these lesions we utilized the C3HeB/FeJ mouse strain
that develops caseous necrosis in response to M. tuberculosis
infection. We demonstrated that [
125I]FIAU-SPECT signal
localized to TB granulomas and confirmed these finding using
post-mortem ex vivo tissue analysis.
The study of mycobacterial pathogenesis can be powerfully
augmented by real-time observational capabilities of novel
imaging biomarkers. Recently, imaging of M. marinum infection
in the transparent zebrafish embryo has provided new insights into
the temporal kinetics between mycobacteria and the host
granuloma [11,12]. However, zebrafish are not mammals and
may therefore have distinct immunological responses to myco-
bacteria. Moreover, studies with M. tuberculosis rather than M.
marinum are likely to be more relevant to human TB pathogenesis.
More recently, Egen et al, used the mouse to produce the first live
images of mycobacterial infection in a mammalian host [13].
Using transgenic mice and 3D time-lapse microscopy, the authors
demonstrate that blood-borne BCG is rapidly taken up by Kupffer
cells in the liver. Though extremely novel, these findings have
limitations; unlike M. tuberculosis, BCG is an attenuated strain and
imaging mouse liver granulomas induced after high-dose intrave-
nous BCG challenge may be less relevant to human pathogenesis
in lungs. Finally, Lewinsohn et al have shown that computed
tomography provides real-time data on TB disease in monkeys,
and has a tight correlation with post-mortem histopathology [14].
In summary, these studies provide proof-of-concept for
application of [
125I]FIAU-SPECT imaging as a novel method
for preclinical and real-time pathogenesis studies in animal models
of TB. Since [
125I]FIAU-SPECT is a non-invasive technology, it
will allow monitoring disease in the same group of animals and
significantly reduce the numbers required per study. This will be
essential to cost-effectively conduct TB studies in the larger and
more expensive animal species (guinea pigs, rabbits, NHP) and
accelerate TB drug and vaccine development. Moreover, this
method will also allow real-time TB pathogenesis studies with
virulent M. tuberculosis species in mammalian hosts, both of which
are likely to be most relevant to human TB pathogenesis.
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